Sl No:
Clinico-pathological parameters
Total no of cases, (n = 220)
% cases with elevated plasma VEGF-A levels
Mean plasma VEGF-A level (pg/mL)
P value
1.
Mensus
0.0565
Pre
63 (28.6%)
68.3% (43/63)
166.5
Post
157 (71.4%)
80.3% (126/157)
172.03
2.
Stage
<0.001
I & II
73 (33.2%)
61.6% (45/73)
95.5
III & IV
128 (58.2%)
85.9% (110/128)
390.7
3.
Grade
0.0026
Low grade
75 (34.1%)
62.7% (47/75)
97.7
High grade
126 (57.3%)
81.8% (103/126)
378.9
4.
Histopathology
<0.001
Serous
134 (60.9%)
87.3% (117/134)
206
Mucinous
40 (18.2%)
50% (20/40)
96
Clear cell
6 (2.7%)
33.3% (2/6)
90.5
Endometrioid
7 (3.2%)
2.9% (2/7)
38
Poorly differentiated
33 (15%)
84.9% (28/33)
184.2
5.
CA-125 levels
<0.001
0<35
23 (10.5%)
52.2% (12/23)
77.8
35-110
26 (11.8%)
53.9% (14/26)
164
110-1000
98 (44.6%)
78.6% (77/98)
367
>1000
73 (33.2%)
90.4% (66/73)
310
6.
Ascites presence
0.4689
Yes
155 (70.5%)
75.5% (117/155)
350
No
65 (29.5%)
80% (52/65)
179
7.
Recurrence in <2 yrs
0.0248
Yes
49 (22.3%)
78% (38/49)
242
No
118 (53.6%)
59.3% (70/118)
110
Table 1:
Correlation between clinico-pathological parameters and plasma VEGF-A levels in the case cohort.
